Company

In 2012 infirst Healthcare was spun out of SEEK a UK based drug discovery group. Its initial products aim to improve treatments for the management of common cough, inflammatory pain, as well as chronic wounds. In the US infirst also develops and markets effective treatments for Gastro Intestinal (GI) symptoms.

Improve

Improve

infirst Healthcare believes that improvements in treatments should be noticeable, perceivable and result in a better quality of life for sufferers. infirst Healthcare aims to contribute to minimising the number of health situations which require escalated and specialised medical intervention.

Knowledge

Knowledge

The company’s Leadership Team has many decades of experience in the pharmaceutical and consumer healthcare industries and they have developed, managed and grown large healthcare businesses and brands in the UK, Europe and North America.

Together

Together

The Leadership Team, Board of Directors and Investors stand united in one common belief that the improvement of known drugs for more effective early intervention of common ailments and symptoms is a worthy cause, a commercial opportunity and a societal need.

Partners

The development of infirst Healthcare’s programme would not have been possible without the invaluable inputs of our many external partners. We would like to thank them for their continued support, shared passion and belief in our mission. 

More information on our partners

1/3 of people - Around a third of people aged 45 years and over in the UK, a total of 8.75 million people, have sought treatment for osteoarthritis
1/3 of people

Around a third of people aged 45 years and over in the UK, a total of 8.75 million people, have sought treatment for osteoarthritis